Nancy Fischbein

Nancy Fischbein

Auto-generated profile, based on publicly available information

Nancy Fischbein

From the Department of Radiology (R.C., N.F., S.M., N.P.), Department of Otolaryngology - Head & Neck Surgery (N.B., L.D.L., F.F.), Stanford University School of Medicine; Department of Radiology (S.M.), VA Palo Alto Healthcare System

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
KHKaren G. Hirsch
Karen G. Hirsch
NFNancy Fischbein
Nancy Fischbein
MMMichael Mlynash
Michael Mlynash
SKStephanie Kemp
Stephanie Kemp
RBRoland Bammer
Roland Bammer
GAGregory Albers
Gregory Albers
Objective To validate quantitative diffusion-weighted imaging (DWI) MRI thresholds that correlate with poor outcome in comatose cardiac arrest survivors, we conducted a clinician-blinded study and prospectively obtained MRIs from comatose patients after cardiac arrest. Methods Consecutive comatose post-cardiac arrest adult patients were prospectively enrolled. MRIs obtained within 7 days after arrest were evaluated. The clinical team was blinded to the DWI MRI results and followed a prescribed prognostication algorithm. Apparent diffusion coefficient (ADC) values and thresholds differentiating good and poor outcome were analyzed. Poor outcome was defined as a Glasgow Outcome Scale score of ≤2 at 6 months after arrest. Results Ninety-seven patients were included, and 75 patients (77%) had MRIs. In 51 patients with MRI completed by postarrest day 7, the prespecified threshold of >10% of brain tissue with an ADC <650 ×10−6 mm2/s was highly predictive for poor outcome with a sensitivity of 0.63 (95% confidence interval [CI] 0.42–0.80), a specificity of 0.96 (95% CI 0.77–0.998), and a positive predictive value (PPV) of 0.94 (95% CI 0.71–0.997). The mean whole-brain ADC was higher among patients with good outcomes. Receiver operating characteristic curve analysis showed that ADC <650 ×10−6 mm2/s had an area under the curve of 0.79 (95% CI 0.65–0.93, p < 0.001). Quantitative DWI MRI data improved prognostication of both good and poor outcomes. Conclusions This prospective, clinician-blinded study validates previous research showing that an ADC 10% of brain tissue in an MRI obtained by postarrest day 7 is highly specific for poor outcome in comatose patients after cardiac arrest.

15 March 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
SAS.A. Amukotuwa
S.A. Amukotuwa
MMM.P. Marks
M.P. Marks
GZG. Zaharchuk
G. Zaharchuk
FCF. Calamante
F. Calamante
RBR. Bammer
R. Bammer
NFN. Fischbein
N. Fischbein
BACKGROUND AND PURPOSE: Intracranial dural arteriovenous fistulas carry a risk of substantial neurologic complications but can be difficult to detect on structural MR imaging and TOF-MRA. The purpose of this study was to assess the accuracy and added value of 3D pseudocontinuous arterial spin-labeling MR imaging for the detection of these lesions. MATERIALS AND METHODS: This retrospective study included 39 patients with a dural arteriovenous fistula and 117 controls who had undergone both DSA and MR imaging with pseudocontinuous arterial spin-labeling. Two neuroradiologists blinded to the DSA results independently assessed MR imaging with and without pseudocontinuous arterial spin-labeling. They recorded specific signs, including venous arterial spin-labeling signal, and the likelihood of a dural arteriovenous fistula using a 5-point Likert scale. Logistic regression and receiver operating characteristic analyses were performed to determine the accuracy of specific signs and the added value of pseudocontinuous arterial spin-labeling. Interobserver agreement was determined by using κ statistics. RESULTS: Identification of the venous arterial spin-labeling signal had a high sensitivity (94%) and specificity (88%) for the presence a dural arteriovenous fistula. Receiver operating characteristic analysis showed significant improvement in diagnostic performance with the addition of pseudocontinuous arterial spin-labeling in comparison with structural MR imaging (Δarea under the receiver operating characteristic curve = 0.179) and a trend toward significant improvement in comparison with structural MR imaging with time-of-flight MRA (Δarea under the receiver operating characteristic curve = 0.043). Interobserver agreement for the presence of a dural arteriovenous fistula improved substantially and was almost perfect with the addition of pseudocontinuous arterial spin-labeling (κ = 0.92). CONCLUSIONS: Venous arterial spin-labeling signal has high sensitivity and specificity for the presence of a dural arteriovenous fistula, and the addition of pseudocontinuous arterial spin-labeling increases confidence in the diagnosis of this entity on MR imaging.

1 April 2016 in Seminars in Radiation Oncology
Verified
Journal Article
Closed access
SHSusan M. Hiniker
Susan M. Hiniker
LMLeslie A. Modlin
Leslie A. Modlin
CCClara Y. Choi
Clara Y. Choi
BABanu Atalar
Banu Atalar
KSKira Seiger
Kira Seiger
SSScott G Soltys
Scott G Soltys

1 February 2020 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
JHJeremy J. Heit
Jeremy J. Heit
NTNeil H. Thakur
Neil H. Thakur
MIMichael Iv
Michael Iv
NFNancy J. Fischbein
Nancy J. Fischbein
MWMax Wintermark
Max Wintermark
GZGregory Zaharchuk
Gregory Zaharchuk


12 September 2019 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MIM. Iv
M. Iv
XLX. Liu
X. Liu
JLJ. Lavezo
J. Lavezo
AGA.J. Gentles
A.J. Gentles
RGR. Ghanem
R. Ghanem
NFN. Fischbein
N. Fischbein
BACKGROUND AND PURPOSE: Fractional tumor burden better correlates with histologic tumor volume fraction in treated glioblastoma than other perfusion metrics such as relative CBV. We defined fractional tumor burden classes with low and high blood volume to distinguish tumor from treatment effect and to determine whether fractional tumor burden can inform treatment-related decision-making. MATERIALS AND METHODS: Forty-seven patients with high-grade gliomas (primarily glioblastoma) with recurrent contrast-enhancing lesions on DSC-MR imaging were retrospectively evaluated after surgical sampling. Histopathologic examination defined treatment effect versus tumor. Normalized relative CBV thresholds of 1.0 and 1.75 were used to define low, intermediate, and high fractional tumor burden classes in each histopathologically defined group. Performance was assessed with an area under the receiver operating characteristic curve. Consensus agreement among physician raters reporting hypothetic changes in treatment-related decisions based on fractional tumor burden was compared with actual real-time treatment decisions. RESULTS: Mean low fractional tumor burden, high fractional tumor burden, and relative CBV of the contrast-enhancing volume were significantly different between treatment effect and tumor (P = .002, P < .001, and P < .001), with tumor having significantly higher fractional tumor burden and relative CBV and lower fractional tumor burden. No significance was found with intermediate fractional tumor burden. Performance of the area under the receiver operating characteristic curve was the following: high fractional tumor burden, 0.85; low fractional tumor burden, 0.7; and relative CBV, 0.81. In comparing treatment decisions, there were disagreements in 7% of tumor and 44% of treatment effect cases; in the latter, all disagreements were in cases with scattered atypical cells. CONCLUSIONS: High fractional tumor burden and low fractional tumor burden define fractions of the contrast-enhancing lesion volume with high and low blood volume, respectively, and can differentiate treatment effect from tumor in recurrent glioblastomas. Fractional tumor burden maps can also help to inform clinical decision-making.